The Innovate Retina series will consist of 2 meetings, 1 virtual and 1 live in-person.
The meetings will focus exclusively on game-changing innovations in medical and surgical retina care, including current management of age-related macular degeneration (AMD) and diabetic retinopathy, ocular imaging, gene therapy, ocular inflammation, surgical technologies, ocular oncology, and the latest advances in retinal pharmacotherapy.
Topics will include late breaking retina pharmacotherapy clinical trials data, current management of neovascular AMD, diabetic macular edema, and diabetic retinopathy, updates on artificial intelligence (AI) for diagnosis, advances in molecular surgery for the precision treatment of previously untreatable blinding diseases, and novel drug delivery technologies designed to improve patient care. We will also focus on the role of imaging in determining new biomarkers for disease. Surgical innovation will be addressed in terms of new instrumentation, visualization enhancements, and image–guided surgery.
At the conclusion of this activity, participants will be able to:
Practicing retina specialists, retinal fellows in training, and vitreoretinal surgeons. Comprehensive ophthalmologists, vision and AI scientists in retina, translational scientists, oncologists and allied physicians, and imaging experts are encouraged to attend.
Diana V. Do, MD
Prithvi Mruthyunjaya, MD, MHS
Director, Stanford Ocular Oncology Service
Quan Dong Nguyen, MD, MSc
Stephen Smith, MD
In collaboration with:
iVista Medical Education, Inc.
Contact Us: firstname.lastname@example.org
Can't make this event? Subscribe here to stay informed on all upcoming events!